| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.59▲ | 2.59▲ | 2.59▲ | 3.69▼ | 2.59▲ |
| MA10 | 2.66▲ | 2.89▼ | 2.89▼ | 4.09▼ | 1.56▲ |
| MA20 | 3.01▼ | 3.27▼ | 3.65▼ | 2.73▲ | 1.03▲ |
| MA50 | 3.92▼ | 4.19▼ | 4.29▼ | 1.41▲ | 0.78▲ |
| MA100 | 4.32▼ | 3.01▼ | 2.34▲ | 0.96▲ | 1.50▲ |
| MA200 | 2.64▲ | 1.71▲ | 1.44▲ | 0.75▲ | 3.48▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.030▲ | -0.050▼ | -0.123▼ | -0.135▼ | 0.390▲ |
| RSI | 39.120▼ | 36.272▼ | 37.506▼ | 51.316▲ | 61.608▲ |
| STOCH | 33.468 | 13.628▼ | 12.929▼ | 39.354 | 36.749 |
| WILL %R | -54.106 | -65.074 | -65.074 | -56.093 | -56.093 |
| CCI | -10.951 | -46.551 | -44.966 | -50.810 | 88.520 |
|
Monday, December 08, 2025 04:54 AM
Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial BiomX continues to see potential in BX011 ...
|
|
Wednesday, December 03, 2025 10:55 PM
WSW, NY, December 4th, 2025, FinanceWireWith antibiotic resistance rising in recent years, the Pentagon has quietly provided ...
|
|
Tuesday, November 25, 2025 01:55 AM
Fintel reports that on November 25, 2025, HC Wainwright & Co. maintained coverage of BiomX (NYSEAM:PHGE) with a Buy recommendation. Analyst Price Forecast Suggests 5,376.27% Upside As of November 17, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/12/25 | 2.63 | 2.80 | 2.63 | 2.785 | 113,212 |
| 09/12/25 | 3.16 | 3.25 | 2.31 | 2.44 | 258,800 |
| 08/12/25 | 3.10 | 3.968 | 2.92 | 3.26 | 798,900 |
| 05/12/25 | 4.80 | 6.03 | 4.80 | 5.17 | 173,857 |
| 04/12/25 | 4.47 | 4.81 | 4.47 | 4.77 | 26,900 |
| 03/12/25 | 4.53 | 4.70 | 4.42 | 4.51 | 48,800 |
| 02/12/25 | 4.40 | 4.91 | 4.24 | 4.70 | 112,800 |
| 01/12/25 | 4.33 | 4.33 | 4.142 | 4.23 | 68,000 |
| 28/11/25 | 4.63 | 4.6384 | 4.125 | 4.36 | 55,891 |
| 26/11/25 | 5.20 | 5.47 | 4.662 | 4.70 | 100,800 |
|
|
||||
|
|
||||
|
|